Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.7K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.7K
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

712
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
712
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

2.3K
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
2.3K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

5.1K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

4.9K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

402
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
402

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concordance Between Patient- and Physician-Reported Improvement With Dupilumab in Atopic Dermatitis.

The Journal of dermatology·2026
Same author

Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis.

The Journal of dermatological treatment·2026
Same author

Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel.

Journal of drugs in dermatology : JDD·2026
Same author

GLP-1RAs and cardiovascular risk reduction in psoriasis: A retrospective cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.

Journal of drugs in dermatology : JDD·2026
Same author

Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence.

Journal of drugs in dermatology : JDD·2026

Related Experiment Video

Updated: Apr 7, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.3K

Screening Recommendations for Chlamydia and Gonorrhea.

Victoria R Sharon1, April W Armstrong2

  • 1Department of Dermatology, University of California, Davis, Sacramento.

JAMA Dermatology
|July 16, 2015
PubMed
Summary
This summary is machine-generated.

Dermatologists can screen for sexually transmitted infections. Current guidelines recommend screening all sexually active females under 25 and at-risk older women for chlamydia and gonorrhea, though evidence for screening men is insufficient.

More Related Videos

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
08:04

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on: February 8, 2019

9.2K
Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.6K

Related Experiment Videos

Last Updated: Apr 7, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.3K
Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
08:04

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on: February 8, 2019

9.2K
Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.6K

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Public Health

Background:

  • Dermatologists encounter sexually transmitted infections (STIs) frequently.
  • There is an opportunity for dermatologists to screen at-risk populations for common STIs.
  • Chlamydia and gonorrhea are prevalent bacterial STIs requiring effective screening strategies.

Purpose of the Study:

  • To outline current United States screening guidelines for chlamydia and gonorrhea.
  • To inform dermatologists about screening recommendations for men and women.
  • To identify at-risk populations for targeted STI screening.

Main Methods:

  • Review of current clinical guidelines and recommendations from major health organizations in the United States.
  • Analysis of evidence supporting screening for chlamydia and gonorrhea in different demographic groups.
  • Synthesis of recommendations for screening frequency and target populations.

Main Results:

  • Screening for chlamydia and gonorrhea is recommended for all sexually active females younger than 25 years.
  • Screening is advised for all women aged 25 years and older who are at increased risk for infection.
  • Evidence supporting routine screening for chlamydia and gonorrhea in men is currently considered insufficient.

Conclusions:

  • Dermatologists play a role in managing and screening for STIs.
  • Targeted screening of sexually active young women and at-risk older women for chlamydia and gonorrhea is crucial.
  • Further research is needed to establish evidence-based screening guidelines for men.